Cancer Control Journal Vol 3, No 5, Supplement CME Pretest

This Journal provides 1 hour of Category I Continuing Medical Education

Complimentary CME Credits

Physicans can earn up to 1 credit hour of Category I for the Physican's Recognition Award of the American Medical Association by reading the material in this supplement and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this article on non-Hodgkin's lymphoma, clinicians will be expected to:

• understand its classification and staging.
• be aware of its incidence and prevalence in the elderly.
• recognize its pathophysiologic causes.
• be aware of its clinical presentation and diagnosis.
• be familiar with treatment options.

This program was planned in accordance with ACCME Essentials.
Release Date: October 1, 1996 Expiration Date: October 1, 1997

Pretest

1. The incidence of NHL increased by what percentage from 1973 to 1987?

a. >25%

b. >50%

c. >100%

d. >200%

2. What tumor marker is included in the International Index predictive model for estimating prognosis for intermediate- and high-grade NHL?

a. bcl-2

b. CD-4

c. CD-8

d. LDH

3. In management of older patients with high-grade lymphomas, the principal factor associated with the best outcome was:

a. addition of supportive therapy

b. age less than 70 years

c. absence of fever at presentation

d. completion of intensive chemotherapy